ISSCR News
New Stem Cell Model of Faulty Alpha Cells that Regulate Blood Sugar in Diabetes
Recently, Quinn Peterson and colleagues from Mayo Clinic, USA, discovered a method for making human alpha cells from cultures of immature stem cells. This work was recently published in Stem Cell Reports.
The ISSCR Signals Concerns About Dangerous and Devastating Cuts to HHS in President Trump’s Draft FY 2026 Budget
The ISSCR joined with more than 500 health and research coalitions and organizations to express concern regarding the Administration’s draft (now proposed) Fiscal Year 2026 budget for the U.S. Department of Health and Human Services (HHS) that proposes a nearly 40% cut to the National Institutes of Health.
In a letter sent to the Chairs and Ranking Members of the Senate and House Appropriations Subcommittees for Labor, Health and Human Services, and Related Agencies, signatories stressed that the proposed FY 2026 budget would cut about one-third of the agency’s discretionary spending and effectively devastate the nation’s research, scientific, and public health infrastructure. Characterized as dangerous and devastating, the budget proposal would put the nation’s health and security at risk.
The ISSCR Announces Montréal as the Location for its 2026 Annual Meeting 8-11 July 2026
Stem cell scientists from around the world will gather in Montréal, Canada, from 8–11 July 2026 for the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting. This global event will unite experts who are leading progress in stem cell research and regenerative medicine. The meeting will center around five key scientific themes curated by the 2026 Annual Meeting Program Committee.
New Guidance from ISSCR Ethics Committee Clarifies Scientific Justification for Stem Cell and Embryo Research
In an article published today in Stem Cell Reports complements the 2021 ISSCR Guidelines for Stem Cell Research and Clinical Translation, providing essential clarification on what constitutes “adequate and appropriate scientific justification” in studies involving human pluripotent stem cells, embryos, and related research.
ISSCR Statement on the Scientific and Therapeutic Value of Human Embryonic Stem Cell Research
Human embryonic stem (hES) cells represent a foundational platform in stem cell science. Their capacity for sustained self-renewal and pluripotency—the ability to differentiate into all cell types in the body—enables critical research into human development, disease mechanisms, and the development of new regenerative medicines.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .